Fernando Rodríguez‐Serrano

1.9k citations
79 papers · 1.5k indexed · h-index 22

Impact in

Papers in

    • Cancer Treatment and Pharmacology 8
    • HER2/EGFR in Cancer Research 6
    • Colorectal Cancer Treatments and Studies 5

Fernando Rodríguez‐Serrano

78 papers receiving 1.4k citations

Peers

Fernando Rodríguez‐Serrano
Comparison fields: 5 of 131
  • Cancer Research 173
  • Genetics 108
  • Organic Chemistry 270
  • Molecular Biology 639
  • Toxicology 31
Replace Guan‐Jun Yang with:
Guan‐Jun Yang China
Isabelle Roland Belgium
Alina Grzanka Poland
Xiaohua Jiang China
Oliver Plettenburg Germany
Steve Weitman United States
Congcong Sun China
Patrícia Severino Brazil
Danuta Duś Poland
Imran Khan United States
Fernando Rodríguez‐Serrano relative to Guan‐Jun Yang China Guan‐Jun Yang's profile →
Citations per field
00.5×6.9×
Guan‐Jun Yang · 1×
Citations per year

Countries citing papers authored by Fernando Rodríguez‐Serrano

Since Specialization
Citations

This map shows the geographic impact of Fernando Rodríguez‐Serrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Rodríguez‐Serrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Rodríguez‐Serrano more than expected).

Fields of papers citing papers by Fernando Rodríguez‐Serrano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Rodríguez‐Serrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Rodríguez‐Serrano. The network helps show where Fernando Rodríguez‐Serrano may publish in the future.

Co-authors

The 25 scholars most cited alongside Fernando Rodríguez‐Serrano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fernando Rodríguez‐Serrano Line = papers co-authored together Fernando Rodríguez‐Serrano links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20213
3 20204
4 201915
5 20186
6 201338
7 201210
8 201212
9 201238
10 201210
11 201112
12 201012
13 201038
14 20099
15 200831
16
Anatomy teaching to physiotherapy students: Preliminary study in the European higher education area setting
20078
17
Methodology in the European higher education area for the Anatomy learning in the Health Sciences
20075
18 200715
19
Examen de salud de niños de la República Árabe Saharaui Democrática (noroeste de África) de vacaciones en España
19983
20
Síndrome CINCA. Un proceso sistémico infrecuente
19981

About Fernando Rodríguez‐Serrano

Fernando Rodríguez‐Serrano is a scholar working on Anatomy, Oncology, Biotechnology, Cancer Research and Molecular Biology, having authored 79 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Cancer therapeutics and mechanisms (6 papers), HER2/EGFR in Cancer Research (6 papers), Cancer Research and Treatments (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Natural product bioactivities and synthesis (5 papers), Virus-based gene therapy research (4 papers) and Chemical Synthesis and Analysis (4 papers). The work is most often cited by research in Cancer Research (173 citations), Genetics (108 citations), Organic Chemistry (270 citations), Molecular Biology (639 citations) and Toxicology (31 citations). Fernando Rodríguez‐Serrano has collaborated with scholars based in Spain, Mexico and United Kingdom. Frequent co-authors include Antonia Aránega, Pablo Álvarez, Juan Antonio Marchal, José Prados, Consolación Melguizo, Houría Boulaiz, José Manuel Garrido, Nuria Mut‐Salud, Esther Carrasco and Octavio Caba. Their work appears in journals such as European Journal of Medicinal Chemistry, Tetrahedron, Biomedicine & Pharmacotherapy, Clinical & Translational Oncology and Cell Biology International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026